Back
BioInvent International AB 10K Form
Sell
22
BOVNF
BioInvent International AB
Last Price:
$3.29
Seasonality Move:
-3.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BOVNF News And Ratings
See the #1 stock for the next 7 days that we like better than BOVNF
BOVNF Financial Statistics
Sales & Book Value
| Annual Sales: | $4.2M |
|---|---|
| Cash Flow: | $-11.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.10 |
| Price / Book: | 2.98 |
Profitability
| EPS (TTM): | -0.47620 |
|---|---|
| Net Income (TTM): | $-31.3M |
| Gross Margin: | $0 |
| Return on Equity: | -37.89% |
| Return on Assets: | -33.88% |
BioInvent International AB Earnings Forecast
Key BioInvent International AB Financial Ratios
-
The Gross Profit Margin over the past 27 years for BOVNF is 0.00%.
-
The Selling, General & Administrative Expenses for BOVNF have been equal to 130.47% of Gross Profit Margin.
-
The Research & Development expenses have been 984.23% of Revenue.
-
The Net Earning history of BOVNF is -960.88% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 11 years.
BioInvent International AB Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BOVNF |
| Website: | bioinvent.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 7.4 |
| Quick Ratio: | 6.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BOVNF Technical Analysis vs Fundamental Analysis
Sell
22
BioInvent International AB (BOVNF)
is a Sell
Is BioInvent International AB a Buy or a Sell?
-
BioInvent International AB stock is rated a SellThe current BioInvent International AB [BOVNF] share price is $3.29. The Score for BOVNF is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.